Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
Recruiting · NCT05601440 · Registry updated 2026-05-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-05-07 | NCT05601440 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Canadian Cancer Trials Group | 73 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Arthur J.E. Child Comprehensive Cancer Centre | Calgary | Canada | 45 |
| BCCA - Kelowna | Kelowna | Canada | 10 |
| BCCA - Vancouver | Vancouver | Canada | 22 |
| Juravinski Cancer Centre at Hamilton Health Sciences | Hamilton | Canada | 60 |
| Kingston Health Sciences Centre | Kingston | Canada | 91 |
| Odette Cancer Centre | Toronto | Canada | 20 |
| Ottawa Hospital Research Institute | Ottawa | Canada | 46 |
| QEII Health Sciences Centre | Halifax | Canada | 11 |
| The Jewish General Hospital | Montreal | Canada | 20 |
| University Health Network | Toronto | Canada | 52 |